This article needs additional citations for
verification. (May 2021) |
![]() | You can help expand this article with text translated from
the corresponding article in Italian. (May 2014) Click [show] for important translation instructions.
|
![]() | |
Clinical data | |
---|---|
AHFS/ Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.048.666 |
Chemical and physical data | |
Formula | C26H15N3O3S |
Molar mass | 449.48 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Fenoverine ( INN) is an antispasmodic [also known as spasmolytics] drug, [1] which acts by inhibiting calcium channels [2] [much in the same way as traditional calcium channel blockers, which are used as antianginal drugs]. In the case of Fenoverine, the relaxation occurs in abdominal / intestinal smooth muscles, while in case of antianginal drugs, the relaxation occurs in coronary vessels. Notably Fenoverine does not act as an antianginal agent.
Fenoverine is known to cause rhabdomyolysis. [2] [3]